However, the primary research paper often cited by that community regarding the drug's potential anti-cancer mechanisms is:
The American Cancer Society and other health authorities emphasize that while laboratory studies exist, Fenbendazole is not FDA-approved for human use, and large-scale clinical trials are still needed to confirm its safety and efficacy in people.
Source: Nature Scientific Reports / PubMed Central Date: August 9, 2018 Key Findings: Fenbendazole.org intersect.rar
It may block glucose uptake in cancer cells by downregulating GLUT transporters , effectively "starving" the tumor.
The drug interferes with tubulin polymerization, a process essential for cancer cell division. However, the primary research paper often cited by
If you are looking for specific types of data, these recent publications are frequently referenced:
Research indicating that the drug may target cancer stem cells, which are often resistant to standard treatments. Fenbendazole Exhibits Antitumor Activity Against Cervical Cancer . If you are looking for specific types of
An overview of the pharmacokinetics and promising biological activities for cancer therapy in both humans and animals. Oral Fenbendazole for Cancer Therapy .